Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MA › Worcester › NPI 1801365663
NP / PA

Boulet, Christina

Boulet, Christina was paid $19K by Medicaid between Feb 2019 and May 2023, across 4 billing codes. Its largest line is 80307, Drug test(s), presumptive, any number of drug classes; immunoassay — 48% of everything it billed.

33Billing provider infoBOULET, CHRISTINA
WORCESTER, MA 01604
33aNPI1801365663assigned 11/21/2018
28Total paid$19K
24GClaims392
24DCodes billed4
24AFirst – last monthFeb 2019 – May 2023
Compared with peers

Next to other Family Nurse Practitioner providers in Massachusetts

Rank by total paid#92 of 327
Median peer was paid$5K
This provider vs. median3.5×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$2.0K$4.0K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2019289$14K
202089$4K
202314$823.44
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 48% 205 155 $9K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 34% 118 102 $6K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 14% 43 41 $3K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 4.2% 26 23 $790.05

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.